FT. LAUDERDALE, Florida., March 8, 2022 /PRNewswire/ — Anju software announced that he had appointed Joe Alea to the Executive Vice President of Product Development. Joe has over 30 years of clinical, healthcare and data analytics experience. Anju Software is a leading provider of comprehensive software solutions for the life science industry, ranging from clinical operations to medical affairs.
“I joined Anju Software because they are positioned to provide a broad range of solutions that enable customers to meet their evolving clinical trial software, medical affairs and data science needs over the long term” , said Mr. Alea. “In addition to our strong product portfolio, I am excited about the future expansion of Anju’s existing products and look forward to developing new solutions that optimize trial design and accelerate data insights.”
Prior to joining Anju Software, Joe held several leadership positions including Global Vice President of Development at Oracle/Phase Forward, and served as Chief Technology Officer at Clinical Ink. Joe brings a mix of strategy, innovation, technology and operations experience that helps companies accelerate growth and solve complex problems. Additionally, Joe has a reputation for delivering quality and timely products by building effective teams, strong discipline, and constantly innovating.
“Joe is the right leader for Anju Software,” said Suhas Gudihal, co-founder and Chief Innovation Officer. “Joe’s extensive software and IT experience and product development skills will help Anju Software strengthen its distribution partnerships, develop strategic alliances, and expand our product portfolio. We believe his strong experience of leadership will help to better target Anju Software.”
Joe’s deep industry experience is extensive and includes positions of increasing responsibility at Oracle Health, Curaspan and Medicity. His multifaceted areas of expertise include digital health, clinical trial management, patient engagement, population health management, digital health and predictive analytics.
“My passion and commitment is to simplify complex business problems to deliver innovative solutions that matter to users, create utility and drive user adoption for increased value and growth,” explained Mr. Chance. “I leverage my versatile mix of experience in strategy, technology, and operations to innovate and develop solutions for healthcare, clinical trials, and data analytics.”
About Anju Software
Anju Software provides an adaptive platform for clinical trials, medical affairs, and a newly designed state-of-the-art clinical data and content repository. It is an AI-based analytics solution combined with data and application integration capabilities, serving the global pharmaceutical, biotech and contract research life sciences markets.
John F. Kouten
JFK Communications, Inc.
(o) 609-241-7352 (c) 908-227-4714
SOURCE Anju Software for Life Sciences